Extending outbreak investigation with machine learning and graph theory: Benefits of new tools with application to a nosocomial outbreak of a multidrug-resistant organism.
Journal
Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
pubmed:
17
9
2022
medline:
17
2
2023
entrez:
16
9
2022
Statut:
ppublish
Résumé
From January 1, 2018, until July 31, 2020, our hospital network experienced an outbreak of vancomycin-resistant enterococci (VRE). The goal of our study was to improve existing processes by applying machine-learning and graph-theoretical methods to a nosocomial outbreak investigation. We assembled medical records generated during the first 2 years of the outbreak period (January 2018 through December 2019). We identified risk factors for VRE colonization using standard statistical methods, and we extended these with a decision-tree machine-learning approach. We then elicited possible transmission pathways by detecting commonalities between VRE cases using a graph theoretical network analysis approach. We compared 560 VRE patients to 86,684 controls. Logistic models revealed predictors of VRE colonization as age (aOR, 1.4 (per 10 years), with 95% confidence interval [CI], 1.3-1.5; We identified risk factors for being a VRE carrier, along with 3 important links with VRE (healthcare personnel, medical devices, patient rooms). Data science is likely to provide a better understanding of outbreaks, but interpretations require data maturity, and potential confounding factors must be considered.
Identifiants
pubmed: 36111457
pii: S0899823X22000666
doi: 10.1017/ice.2022.66
pmc: PMC9929710
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
246-252Références
J Hosp Infect. 2016 Nov;94(3):236-241
pubmed: 27645212
Curr Infect Dis Rep. 2019 May 22;21(7):22
pubmed: 31119397
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1457-1462
pubmed: 30394238
J Hosp Infect. 2019 Jan;101(1):69-75
pubmed: 30026006
PLoS One. 2020 Jul 7;15(7):e0235690
pubmed: 32634158
Clin Infect Dis. 2018 Jan 6;66(1):149-153
pubmed: 29020316
J Hosp Infect. 2018 Dec;100(4):e216-e225
pubmed: 29475013
Euro Surveill. 2022 Dec;27(48):
pubmed: 36695463
Microorganisms. 2019 Sep 26;7(10):
pubmed: 31561632
Sci Rep. 2019 Oct 15;9(1):14811
pubmed: 31616035
Clin Infect Dis. 2004 Oct 1;39(7):964-70
pubmed: 15472847
J Hosp Infect. 2018 Feb;98(2):202-211
pubmed: 28807836
Nat Microbiol. 2021 Jan;6(1):103-111
pubmed: 33106672
Infection. 2019 Feb;47(1):7-11
pubmed: 30178076
Ann Intern Med. 2002 Jun 4;136(11):834-44
pubmed: 12044132
Am J Epidemiol. 2019 Dec 31;188(12):2222-2239
pubmed: 31509183
Sci Rep. 2012;2:292
pubmed: 22379597
J Antimicrob Chemother. 2013 Apr;68(4):731-42
pubmed: 23208830
Euro Surveill. 2018 Jul;23(29):
pubmed: 30043725
PLoS One. 2017 Apr 25;12(4):e0176438
pubmed: 28441422
Antimicrob Resist Infect Control. 2021 Feb 18;10(1):38
pubmed: 33602300
Infect Control Hosp Epidemiol. 2016 Jan;37(1):26-35
pubmed: 26434609
Clin Microbiol Infect. 2020 Oct;26(10):1291-1299
pubmed: 32061798
Curr Infect Dis Rep. 2018 Apr 27;20(6):12
pubmed: 29704133
Infect Control Hosp Epidemiol. 2017 Feb;38(2):203-215
pubmed: 27825401
Microorganisms. 2020 Jan 31;8(2):
pubmed: 32024001